top of page
it's where dermatology lives
by Cory Perla
Oct 2, 20191 min read
Study: Combination of Two Immunotherapies Brings Advanced Melanoma Survival Rate up to 50% for First
By combining two existing therapies, researchers found that they have been able to stop or reverse the progression of advanced melanoma.
Derm City
Jun 3, 20161 min read
New class of drugs shows promise against BRAF-inhibitor-resistant melanoma
Researchers from Nice, France, have tested a new class of drugs—thiazole benzensulfonamides or TZBs—in melanoma and are getting promising...
Featured Posts
bottom of page